Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Acute Promyelocytic Leukemia in the Molecular Age

Navin Bhatt, Michelle Becker, Juana Martinez, Hannah Levavi, Kyle Farina, Marina Kremyanskaya, Bridget Kelly Marcellino, Alan Shih, Lewis R. Silverman, Vesna Najfeld, John O. Mascarenhas, Douglas Tremblay, Jonathan Feld

Blood (2024) 144 (Supplement 1): 6131.

https://doi.org/10.1182/blood-2024-211957

Published: 2024

Journal Articles

TET2 and TP53 Mutations Cooperate in Leukemia Development and Modulate the Response to Inflammation

Pablo Sanchez Vela, Brianna Kelly, Claudia Brady, Jonathan Foox, Jacob Glass, Ross L Levine, Alan Shih

Blood (2024) 144 (Supplement 1): 2712.

https://doi.org/10.1182/blood-2024-202521

Published: 2024

Journal Articles

A Novel Three-Way Translocation Involving ETV6-IL3 Drives AML with Eosinophilia

Ariel Siegel, Joseph Tripodi, Brianna Kelly, Sebastian Elghaity-Beckley, Michelle Becker, Douglas Tremblay, Jonathan Feld, Hannah Levavi, Marina Kremyanskaya, Bridget Kelly Marcellino, Christian Salib, Alla Keyzner, Amy Duffield, John O. Mascarenhas, Vesna Najfeld, Alan Shih

Blood (2024) 144 (Supplement 1): 6098.

https://doi.org/10.1182/blood-2024-203588

Published: 2024

Journal Articles

Development of a Fully Immunocompetent Adoptive Transfer In Vivo Model of Npm1 cA ;Idh2 R140Q ;Flt3 ITD AML

Chia Sharpe, Mariah Johnson, Sydney Fobare, Ola A. Elgamal, Bonnie K. Harrington, Allison Mustonen, Kinsey Bryant, Carolyn Cheney, James R. Lerma, Jean Truxall, Casie Furby, Marissa Long, Kaytlynn Fyock, Alan Shih, Ross L Levine, Erin K. Hertlein, John C. Byrd

Blood (2023) 142 (Supplement 1): 1386.

https://doi.org/10.1182/blood-2023-189975

Published: 2023

Journal Articles

Phase 1/2 Study of Pacritinib in Combination with Azacitidine in Chronic Myelomonocytic Leukemia

Douglas Tremblay, Alan Shih, Jonathan Feld, Erin Moshier, John Mascarenhas

Blood (2023) 142 (Supplement 1): 3248.

https://doi.org/10.1182/blood-2023-174960

Published: 2023

Journal Articles

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response

Michael D. Amatangelo, Lynn Quek, Alan Shih, Eytan M. Stein, Mikhail Roshal, Muriel D. David, Benoit Marteyn, Noushin Rahnamay Farnoud, Stephane de Botton, Olivier A. Bernard, Bin Wu, Katharine E. Yen, Martin S. Tallman, Elli Papaemmanuil, Virginie Penard-Lacronique, Anjan Thakurta, Paresh Vyas, Ross L. Levine

Blood (2017) 130 (6): 732–741.

https://doi.org/10.1182/blood-2017-04-779447

Published: 2017

Includes: Supplemental data

NARROW

Acute Promyelocytic Leukemia in the Molecular Age

TET2 and TP53 Mutations Cooperate in Leukemia Development and Modulate the Response to Inflammation

A Novel Three-Way Translocation Involving ETV6-IL3 Drives AML with Eosinophilia

Development of a Fully Immunocompetent Adoptive Transfer In Vivo Model of Npm1 cA ;Idh2 R140Q ;Flt3 ITD AML

Phase 1/2 Study of Pacritinib in Combination with Azacitidine in Chronic Myelomonocytic Leukemia

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response

Email alerts

ASH Publications

American Society of Hematology

Acute Promyelocytic Leukemia in the Molecular Age

TET2 and TP53 Mutations Cooperate in Leukemia Development and Modulate the Response to Inflammation

A Novel Three-Way Translocation Involving ETV6-IL3 Drives AML with Eosinophilia

Development of a Fully Immunocompetent Adoptive Transfer In Vivo Model of Npm1 cA ;Idh2 R140Q ;Flt3 ITD AML

Phase 1/2 Study of Pacritinib in Combination with Azacitidine in Chronic Myelomonocytic Leukemia

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only